Delivery Order SPE2DB20D3101-SPE2DB24FQXM8
Award Date 12/21/23
Potential Completion Date 12/22/23
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,871.68 firm-fixed-price delivery order is for the supply of 4,565,220,609 units of Ondansetron HCL 8 mg tablets. The contract has a period of performance through July 23, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,182.40 firm fixed-price delivery order is for the supply of 4,565,098,253 units of ondansetron HCL 8 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,817.62 Firm Fixed Price Delivery Order is for the supply of 4,563,265,608 units of Ondansetron HCL 8 mg Tablets in 30-count packages. The contract has a period of performance through January 9, 2024 and does not include any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,190.14 firm fixed-price delivery order is for the supply of 4,567,861,141 units of the medication Ondansetron HCL 8 mg Tablet. The contract has an ultimate completion date of April 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,330.41 firm fixed-price delivery order is for the supply of 4,566,471,926 units of Ondansetron HCL 8 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,260.13 Firm Fixed Price Delivery Order is for the provision of 4,562,704,057 units of Ondansetron HCL 8 mg Tablets, with an ultimate completion date of November 6, 2023. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.64 firm-fixed-price delivery order covers the supply of 4,566,135,427 units of Ondansetron HCL 8 mg Tablets in 30-count packages, with a period of performance through October 18, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,377.65 firm-fixed-price delivery order is for the supply of 4,565,219,948 units of the medication Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,220.78 firm fixed-price delivery order is for the supply of 4,562,781,320 units of the generic medication Ondansetron HCL 8 mg tablets. The award has an ultimate completion date of November 13, 2023 and was not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,121.20 delivery order contract is for the supply of 4,568,160,360 units of Ondansetron HCL 8 mg tablets. The contract is a firm fixed-price, non-set-aside agreement with a performance period through May 7, 2025. Amerisourcebergen Drug Corp is the prime contractor and there are no subcontractors referenced. This...